Financials
- Market Capitalization 24.49 M
- Employee 129
- Founded 1997
- CEO N/A
- Website www.cytosorbents.com
- Headquarter Delaware, United States
- FIGI BBG000C3P8V0
- Industry Medical Devices
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4476 | MOVE Corvex, Inc. - Common Stock | 15.53 USD | +2.98% | -6.73% | -20.15% | +2289.23% | 30.77 M USD | ||
| 4532 | PLSM Pulsenmore Ltd. - Ordinary Shares | 3.89 USD | +7.46% | -11.39% | +2.37% | -56.05% | 25.30 M USD | ||
| 4573 | LFWD Lifeward Ltd. - Ordinary Shares | 8.00 USD | -0.62% | -5.33% | +13.15% | +1409.43% | 22.52 M USD | ||
| 4600 | NMTC NeuroOne Medical Technologies Corporation - Common Stock | 2.43 USD | -8.65% | -19.80% | -27.68% | +242.25% | 20.95 M USD |
Frequently asked questions about Cytosorbents Corporation - Common Stock
What is the Cytosorbents Corporation - Common Stock stock price today?
The current price of Cytosorbents Corporation - Common Stock (CTSO) is 0.39. Over the past 24 hours, the stock has changed by +2.63%. Follow the CTSO chart for real-time price dynamics.
What is the stock ticker of Cytosorbents Corporation - Common Stock?
Cytosorbents Corporation - Common Stock trades under the ticker CTSO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cytosorbents Corporation - Common Stock stock going up?
CTSO has changed by -4.88% over the last week, -20.41% over the last month, and -62.50% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cytosorbents Corporation - Common Stock net income for the last quarter?
Cytosorbents Corporation - Common Stock reported net income of -5.13 M for the last quarter. The previous quarter showed -5.5 M, which means net income changed by +6.68%.
How many employees does Cytosorbents Corporation - Common Stock have?
As of the latest available data, Cytosorbents Corporation - Common Stock has 129 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cytosorbents Corporation - Common Stock EBITDA?
Cytosorbents Corporation - Common Stock EBITDA is -2.4 M, and its EBITDA margin is -27.11%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cytosorbents Corporation - Common Stock stock?
You can buy Cytosorbents Corporation - Common Stock (CTSO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cytosorbents Corporation - Common Stock stock?
Investing in Cytosorbents Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTSO chart and related analysis on metatrader.com as part of your research.